ResearchMoz presents professional and in-depth study of "Infectious Disease Drugs: The Chinese Market".
Report Highlights
The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377126
Report Includes
An overview of the Chinese market for infectious disease drugs.
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
Examination of technological developments, future trends, and emerging opportunities.
Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
Profiles of major players in the field of infectious disease treatments.
Report Scope
The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.
The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/infectious-disease-drugs-the-chinese-market-report.html/toc
In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.
More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.
Table Of Contents
Chapter 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 SUMMARY
LARGEST AND FASTEST-GROWING MARKETS
LARGEST INFECTIOUS DISEASE DRUG MARKETS
FAST-GROWING INFECTIOUS DISEASE DRUG MARKETS
LAWS, REGULATIONS AND TARGETS
PHARMACEUTICAL ADMINISTRATION LAW OF THE PEOPLE'S REPUBLIC OF CHINA
PROCUREMENT AND BIDDING MANAGEMENT OF THE CHINA FOOD AND DRUG ADMINITRATION
ADMINISTRATIVE MEASURES FOR THE CLINICAL USE OF ANTIBACTERIAL DRUGS
LIMITATION OF ANTIBACTERIAL DRUGS
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377126
Chapter 3 THE CHINESE DRUG MARKET
CHINESE DRUG MARKET BY SALES CHANNELS
SUPPLY CHAIN AND PRICING STRUCTURE
Hospitals
Retailers
RETAIL MARKET
Chinese Drug Retail Market by Drug Type
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Report Highlights
The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377126
Report Includes
An overview of the Chinese market for infectious disease drugs.
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
Examination of technological developments, future trends, and emerging opportunities.
Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
Profiles of major players in the field of infectious disease treatments.
Report Scope
The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.
The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/infectious-disease-drugs-the-chinese-market-report.html/toc
In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.
More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.
Table Of Contents
Chapter 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 SUMMARY
LARGEST AND FASTEST-GROWING MARKETS
LARGEST INFECTIOUS DISEASE DRUG MARKETS
FAST-GROWING INFECTIOUS DISEASE DRUG MARKETS
LAWS, REGULATIONS AND TARGETS
PHARMACEUTICAL ADMINISTRATION LAW OF THE PEOPLE'S REPUBLIC OF CHINA
PROCUREMENT AND BIDDING MANAGEMENT OF THE CHINA FOOD AND DRUG ADMINITRATION
ADMINISTRATIVE MEASURES FOR THE CLINICAL USE OF ANTIBACTERIAL DRUGS
LIMITATION OF ANTIBACTERIAL DRUGS
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377126
Chapter 3 THE CHINESE DRUG MARKET
CHINESE DRUG MARKET BY SALES CHANNELS
SUPPLY CHAIN AND PRICING STRUCTURE
Hospitals
Retailers
RETAIL MARKET
Chinese Drug Retail Market by Drug Type
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment